These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28608326)

  • 41. Evaluation of extracellular volume fraction thresholds corresponding to myocardial late-gadolinium enhancement using cardiac magnetic resonance.
    Hwang SH; Choi EY; Park CH; Paek MY; Greiser A; Kim TH; Choi BW
    Int J Cardiovasc Imaging; 2014 Dec; 30 Suppl 2():137-44. PubMed ID: 25022430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3D SASHA myocardial T1 mapping with high accuracy and improved precision.
    Nordio G; Bustin A; Henningsson M; Rashid I; Chiribiri A; Ismail T; Odille F; Prieto C; Botnar RM
    MAGMA; 2019 Apr; 32(2):281-289. PubMed ID: 30191345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot.
    Chen CA; Dusenbery SM; Valente AM; Powell AJ; Geva T
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):1-10. PubMed ID: 26684969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myocardial T1 mapping for patients with implanted cardiac devices using wideband inversion recovery spoiled gradient echo readout.
    Shao J; Rashid S; Renella P; Nguyen KL; Hu P
    Magn Reson Med; 2017 Apr; 77(4):1495-1504. PubMed ID: 27018872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endogenous assessment of diffuse myocardial fibrosis in patients with T
    van Oorschot JW; Güçlü F; de Jong S; Chamuleau SA; Luijten PR; Leiner T; Zwanenburg JJ
    J Magn Reson Imaging; 2017 Jan; 45(1):132-138. PubMed ID: 27309545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Superiority of the extracellular volume fraction over the myocardial T1 value for the assessment of myocardial fibrosis in patients with non-ischemic cardiomyopathy.
    Inui K; Tachi M; Saito T; Kubota Y; Murai K; Kato K; Takano H; Amano Y; Asai K; Shimizu W
    Magn Reson Imaging; 2016 Oct; 34(8):1141-5. PubMed ID: 27215951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Native T1 Relaxation Time and Extracellular Volume Fraction as Accurate Markers of Diffuse Myocardial Fibrosis in Heart Valve Disease　- Comparison With Targeted Left Ventricular Myocardial Biopsy.
    Kockova R; Kacer P; Pirk J; Maly J; Sukupova L; Sikula V; Kotrc M; Barciakova L; Honsova E; Maly M; Kautzner J; Sedmera D; Penicka M
    Circ J; 2016 Apr; 80(5):1202-9. PubMed ID: 26984717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
    Kammerlander AA; Marzluf BA; Zotter-Tufaro C; Aschauer S; Duca F; Bachmann A; Knechtelsdorfer K; Wiesinger M; Pfaffenberger S; Greiser A; Lang IM; Bonderman D; Mascherbauer J
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):14-23. PubMed ID: 26684970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of Myocardial Fibrosis Using Multimodality Imaging in Severe Aortic Stenosis: Comparison With Histologic Fibrosis.
    Park SJ; Cho SW; Kim SM; Ahn J; Carriere K; Jeong DS; Lee SC; Park SW; Choe YH; Park PW; Oh JK
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):109-119. PubMed ID: 30448148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.
    Neilan TG; Coelho-Filho OR; Shah RV; Abbasi SA; Heydari B; Watanabe E; Chen Y; Mandry D; Pierre-Mongeon F; Blankstein R; Kwong RY; Jerosch-Herold M
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):672-83. PubMed ID: 23643283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between the cardiac magnetic resonance derived extracellular volume fraction and feature tracking myocardial strain in patients with non-ischemic dilated cardiomyopathy.
    Azuma M; Kato S; Kodama S; Hayakawa K; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K
    Magn Reson Imaging; 2020 Dec; 74():14-20. PubMed ID: 32898651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human non-contrast T1 values and correlation with histology in diffuse fibrosis.
    Bull S; White SK; Piechnik SK; Flett AS; Ferreira VM; Loudon M; Francis JM; Karamitsos TD; Prendergast BD; Robson MD; Neubauer S; Moon JC; Myerson SG
    Heart; 2013 Jul; 99(13):932-7. PubMed ID: 23349348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
    Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
    Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients.
    Treibel TA; López B; González A; Menacho K; Schofield RS; Ravassa S; Fontana M; White SK; DiSalvo C; Roberts N; Ashworth MT; Díez J; Moon JC
    Eur Heart J; 2018 Feb; 39(8):699-709. PubMed ID: 29020257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis.
    Lee SP; Lee W; Lee JM; Park EA; Kim HK; Kim YJ; Sohn DW
    Radiology; 2015 Feb; 274(2):359-69. PubMed ID: 25251584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Importance of standardizing timing of hematocrit measurement when using cardiovascular magnetic resonance to calculate myocardial extracellular volume (ECV) based on pre- and post-contrast T1 mapping.
    Engblom H; Kanski M; Kopic S; Nordlund D; Xanthis CG; Jablonowski R; Heiberg E; Aletras AH; Carlsson M; Arheden H
    J Cardiovasc Magn Reson; 2018 Jun; 20(1):46. PubMed ID: 29950178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.
    Liu S; Han J; Nacif MS; Jones J; Kawel N; Kellman P; Sibley CT; Bluemke DA
    J Cardiovasc Magn Reson; 2012 Dec; 14(1):90. PubMed ID: 23272704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.